The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.5K Targets. Of those, 1.6M data for 765K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

27 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Cmpds
Data
Article Title
Organization
1
Oxaspirol B with p97 Inhibitory Activity and Other Oxaspirols from Lecythophora sp. FL1375 and FL1031, Endolichenic Fungi Inhabiting Parmotrema tinctorum and Cladonia evansii.EBI
University of Arizona
6
Structure-Activity Study of Bioisosteric Trifluoromethyl and Pentafluorosulfanyl Indole Inhibitors of the AAA ATPase p97.EBI
University of Pittsburgh
92
Discovery of 2-(cyclohexylmethylamino)pyrimidines as a new class of reversible valosine containing protein inhibitors.EBI
Nerviano Medical Sciences
112
Alkylsulfanyl-1,2,4-triazoles, a new class of allosteric valosine containing protein inhibitors. Synthesis and structure-activity relationships.EBI
TBA
27
2-Anilino-4-aryl-1,3-thiazole inhibitors of valosin-containing protein (VCP or p97).EBI
Kyowa Hakko Kogyo
3
NVP-BHG712: Effects of Regioisomers on the Affinity and Selectivity toward the EPHrin Family.EBI
Johann Wolfgang Goethe University
26
Optimization of 1,2,4-Triazole-Based p97 Inhibitors for the Treatment of Cancer.EBI
University of Pittsburgh Chemical Diversity Center
37
Synthesis and structure-activity relationships of N - (3 - (1H-imidazol-2-yl) phenyl) - 3-phenylpropionamide derivatives as a novel class of covalent inhibitors of p97/VCP ATPase.EBI
Chinese Academy of Medical Sciences and Peking Union Medical College
72
The Emerging Landscape of Small-Molecule Therapeutics for the Treatment of Huntington's Disease.EBI
Aligarh Muslim University
19
Discovery of a new class of valosine containing protein (VCP/P97) inhibitors for the treatment of colorectal cancer.EBI
Nanjing Normal University
10
AAA ATPases as therapeutic targets: Structure, functions, and small-molecule inhibitors.EBI
California Institute of Technology
23
Discovery of novel pyrimidine molecules containing boronic acid as VCP/p97 Inhibitors.EBI
Nanjing Normal University
28
A covalent p97/VCP ATPase inhibitor can overcome resistance to CB-5083 and NMS-873 in colorectal cancer cells.EBI
California Institute of Technology
22
Allosteric Indole Amide Inhibitors of p97: Identification of a Novel Probe of the Ubiquitin Pathway.EBI
University of Pittsburgh
19
Discovery of Irreversible p97 Inhibitors.EBI
University of Minnesota
18
p97: An Emerging Target for Cancer, Neurodegenerative Diseases, and Viral Infections.EBI
TBA
17
Discovery of a new class of valosine containing protein (VCP/P97) inhibitors for the treatment of non-small cell lung cancer.EBI
Nanjing Normal University
65
Discovery of a First-in-Class, Potent, Selective, and Orally Bioavailable Inhibitor of the p97 AAA ATPase (CB-5083).EBI
Cleave Biosciences
23
Optimization of Phenyl Indole Inhibitors of the AAA+ ATPase p97.EBI
University of Pittsburgh Chemical Diversity Center
2
ATP-competitive, marine derived natural products that target the DEAD box helicase, eIF4A.EBI
University of Arizona
4
Organosilicon carriers for use in treating infections and/or diseases caused by SARS virusesBDB
Individual
14
CGRP receptor antagonistsBDB
Heptares Therapeutics
44
Substituted 2-phenyl (AZA)benzofuran compounds for the treatment of hepatitis CBDB
Bristol Myers Squibb
57
Xanthine derivatives, their use as a medicament, and pharmaceutical preparations comprising the sameBDB
Max Delbruck Center
19
2-heteroaryl carboxamidesBDB
Bayer Intellectual Property
7
Cloning and expression of a human serotonin 5-HT4 receptor cDNA.BDB
Janssen Research Foundation